Status:
COMPLETED
Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly
Lead Sponsor:
Biosearch S.A.
Conditions:
SARS CoV-2 Infection
Elderly
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The objective of this trial is to evaluate the effect of the consumption of a probiotic strain on the incidence and severity of COVID-19 in elderly population living in a nursing home. In addition, it...
Detailed Description
The working hypothesis is that the administration of a Lactobacillus strain improves the immune response in the elderly population, improving the immune response to a possible COVID-19 infection. The ...
Eligibility Criteria
Inclusion
- Person over 60 years of age.
- Intern in residence for the elderly.
- Sign informed consent.
Exclusion
- Person who at some previous time has tested positive for detection of COVID-19 by PCR or serology.
- Person who at the time of starting the intervention presents symptoms compatible with COVID-19.
- Person with concomitant disease type HIV, transplant, active cancer or other type of active immunosuppression.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT04756466
Start Date
January 1 2021
End Date
December 31 2021
Last Update
October 21 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Residencia San Marcos
Santiago de Compostela, A Coruña, Spain, 15820
2
Residencia Santa Olalla
Santiago de Compostela, A Coruña, Spain, 15881
3
Residencia San Simon de Ons
Santiago de Compostela, A Coruña, Spain, 15883